Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Cloning of HCAP1 and studies on its primary function

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Two Variants of the Human Hepatocellular Carcinoma‐associated HCAP1 Gene and Their Effect on the Growth of the Human Liver Cancer Cell Line Hep3B

Isolation of cDNA Clones Using PAC and BAC Probes

Cloning and Characterization of A Novel Gene (c17orf25) from the Deletion Region on Chromosome 17p13.3 in Hepatocelular Carcinoma

Cloning and Identification of a Novel Gene HCCA3 Highly Expressed in Human Hepatocellular Carcinoma and Its Clinicopathological Significance

Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma

Molecular Clone And Functional Study Of A Novel Hepatoma Associated Gene

[Effects of Two Haplotypes of HCAP1 Gene on Cellular Gene Expression Levels in a Human Hepatocarcinoma Cell Line Hep3B].

The Cloning of a New Liver Cancer Related Gene and Preparation of T He Antibody

Cloning and expression of a human liver cancer related gene

[Cloning, prokaryotic expression and polyclonal antibody preparation of HCCR: a new biomarker for hepatocellular carcinoma].

Identification of hepatocellular carcinoma antigens by serological analysis of recombinant cDNA expression library and detection of hcct-19 expression in human tissues and cell lines

Screening and cloning of target genes transactivated by human gene C1 encoding protein 1 interacting with HBV core antigen using suppression subtractive hybridization technique

Cloning and identification of human gene 2 transactivated by nonstructural protein 3 of hepatitis C virus

A Novel Growth Suppressor Gene on Chromosome 17p13.3 with a High Frequency of Mutation in Human Hepatocellular Carcinoma.

Cloning and Expression of Ribosomal Protein L26 in Hepatocellular Carcinoma

HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein.

Expression and Function of CL-L1 in Hepatocellular Carcinoma

Construction and Screening of Suppression Subtractive Hybridization Library of Human Primary Hepatocellular Carcinoma

Analysis Hepatocellular Carcinoma Relative Antigen Gene HCC-A-12 Applying Bioinformatics